We describe a non-isotopic, semi-automated method for large-scale multiplex analysis of nucleic acid sequences, using the cystic fibrosis transmembrane regulator (CFTR) gene as an example. Products of a multiplex oligonucleotide ligation assay (OLA) are resolved electrophoretically from one another and from unligated probes under denaturing conditions with fluorescence detection. One ligation probe for each OLA target carries a fluorescent tag, while the other probe carries an oligomeric non-nucleotide mobility modifier. Each OLA product has a unique electrophoretic mobility determined by the ligated oligonucleotides and the mobility-modifier oligomer arbitrarily assigned (coded) to its target. The mobility range for practical mobility modifiers is much wider than the accessible range from unmodified ligated oligonucleotides of practical length. Each mobility modifier is built from phosphoramidite monomers in a stepwise manner on its associated oligonucleotide using an automated synthesizer. The resulting mobility modifiers lower the probe-target duplex T m by less than 3°C and retard probe-target annealing by less than 50%, with negligible effect on OLA yield and specificity. This method is especially useful for allelic discrimination in highly polymorphic genes such as CFTR.
INTRODUCTION
Large-scale multiplex analysis of highly polymorphic loci is needed for practical identification of individuals, e.g., for paternity testing and in forensic science (1) , for organ-transplant donor-recipient matching (2, 3) , for genetic disease diagnosis, prognosis, and pre-natal counseling (4, 5) , and for the study of oncogenic mutations (6, 7) . In addition, the cost-effectiveness of infectious disease diagnosis by nucleic acid analysis varies directly with the multiplex scale in panel testing. Many of these applications depend on the discrimination of single-base differences at a multiplicity of sometimes closely spaced loci.
Three classes of assay dominate the field of allelic discrimination: (a) solid-phase probe-target hybridization [e.g., in microtiter plates (8) , on direct dot blots (9) or on reverse dot blots (10, 11) ], (b) allele-specific polymerase chain reaction (PCR) (12, 13) , and (c) allele-specific OLA or ligase chain reaction (14) (15) (16) . Recently a solution-phase nick-translation PCR assay, in which the probe was digested during thermal cycling to generate a fluorescent signal, distinguished alleles without resorting to a post-amplification separation (17) .
Until now, none of these methods has been adapted to the practical needs of large-scale multiplex analysis. Solid-phase hybridization assays require multiple liquid-handling steps, and some incubation and wash temperatures must be carefully controlled to keep the stringency needed for single-nucleotide mismatch discrimination. Because a given assay uses a single signal chemistry, the signals for different alleles in the same test sample must be distinguished by spacial location, placing an additional burden on the user to avoid scrambling signals from different alleles or samples.
In allele-specific PCR discrimination arises from the mixture of primers in a given amplification tube and is scored by the presence or absence of a product band in a gel. This approach requires splitting of the test sample among multiple reaction tubes with different primer combinations, again multiplying liquid transfers and opportunities for scrambled results. PCR has also discriminated alleles by attaching different fluorescent dyes to competing allelic primers in a single reaction tube (18) , but this route to multiplex analysis is limited in scale by the relatively few dyes which can be spectrally resolved with existing instrumentation and dye chemistry. These same limitations apply to multiplex allelic discrimination by solution-phase nicktranslation PCR (19, 20) .
Ligation of allele-specific probes generally has used solid-phase capture (8, 14) or size-dependent separation (15, 16) to resolve the allelic signals, the latter method being limited in multiplex scale by the narrow size range of ligation probes.
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The multiplexed DNA probe assay described here uses fluorescently monitored electrophoresis to resolve ligated, chemically modified oligonucleotide probes from one another and from un-ligated probes. The present probes bear non-nucleotide tails which allow the mobility of each ligation product to be arbitrarily defined, regardless of oligonucleotide length or sequence. The mobility modifiers themselves are oligomeric, making them suitable for assembly on the probes during automated oligonucleotide synthesis. This approach to multiplex analysis is called Sequence-Coded Separation, to highlight both the decoupling of mobility from the physical size of the ligated probe and the deliberately designed linkage between mobility and target sequence.
The cystic fibrosis transmembrane regulator (CFTR) gene was first found in 1989 (21) (22) (23) . Since that time over 400 mutations have been discovered, of which about 30 occur with a statistical frequency greater that 0.2% (24) . Here we show application of this multiplex technology to the analysis of 9 of these mutations clustered in 2 exons of the CFTR gene.
MATERIALS AND METHODS

Synthesis of modified oligonucleotide probes
Synthesis of oligonucleotides with a 5' oligomeric hexaethyleneoxide (HEO) tail. A 15 to 30 nucleotide (nt) support-bound oligonucleotide was synthesized using a Model 380B or 394 automated DNA synthesizer (Applied Biosystems Division of the Perkin Elmer Corporation, Foster City, CA). The oligonucleotide was coupled with 1 to 24 HEO-phosphoramidite units (25) (26) (27) using standard synthesis cycles, and cleaved from the synthesis support, purified and detritylted using standard DNA synthesis protocols.
Synthesis of oligonucleotides with a 3' oligomeric HEO tail and a 5' phosphate. A support-bound nucleoside, usually T, was coupled with 1 to 24 HEO-phosphoramidite units followed by 15 to 30 nt phosphoramidites using a Model 380B or 394 automated DNA synthesizer (Applied Biosystems Division of the Perkin Elmer Corporation, Foster City, CA) with standard DNA synthesis cycles. This was followed by 5' phosphorylation using 5' Phosphate-ON™ chemistry (Clontech, Palo Alto, CA) as described by Horn and Urdea (28) . The product was purified by HPLC as described above.
Synthesis of oligonucleotides with a 3' fluorescein and a 5'
phosphate. A 25 nt oligonucleotide was synthesized with a standard synthesis cycle using a Model 380B or 394 automated synthesizer (Applied Biosystems Division of the Perkin Elmer Corporation, Foster City, CA) using 3'-DMT-C6-Amine-ON™ CPG (Clontech, Palo Alto, CA) as the synthesis support. The oligonucleotide was then 5'phosphorylated using the 5'-Phosphate-ON™ reagent (Clontech, Palo Alto, CA). The amino-oligonucleotide was purified by HPLC as described above. The solvent was then removed and the amino-oligonucleotide was dissolved in 30 /tl of a 0.25 M NaHCO 3 /Na 2 CO 3 pH 9.0 buffer solution and was added to a solution of 1 mg 6-Carboxyfluorescein-N-hydroxysuccinimide ester (FAM-NHS) (Research Organics, Inc., Clevland, OH) in 70 jil of dimethylformamide and incubated for several hours at room temperature. The labeled oligonucleotide was purified by gel-exclusion chromatography on a PD-10 Sephadex column (Pharmacia, Uppsala, Sweden), followed by HPLC as described above to give die purified product.
Melting measurements
For each T m measurement, a probe and a target oligonucleotide containing the probe-complementary sequence (see Table I , lines 1 -9) were spectrophotometrically assayed using nearest-neighbor extinction coefficients (29) These included GM07224 (normal), GM11496B (G542X homozygote), and GM11274 (D551/AF508). Lymphoblast cultures were pelleted by centrifugation, washed with phosphate buffered saline (PBS), resuspended in proteinase K digestion buffer (100 mM NaCl, 10 mM Tris-HCl pH 8.0, 25 mM EDTA, 0.5% SDS containing 100 /tg/ml proteinase K) and incubated overnight at 50°C. DNA was extracted, precipitated, and resuspended in a small volume of sterile distilled water (30) . Genomic DNA from peripheral blood cells containing known CFTR gene mutations was kindly provided by F.Chehab and J.Wall (UCSF DNA Diagnostic Laboratory) (31,32). 
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Oligonucleotide ligation assay kinetics study For the study of ligation reaction kinetics, probe concentrations were 5 nM, and oligonucleotide target concentration was 0.5 nM. Each upstream probe (Table I , line 11) was 5' end-modified with an (HEO) n -unit (n = 0, 1, 3, 9, 10, 11, 23, 24), and the downstream probe (Table I , line 10) was 3' end-labeled with a FAM dye. The target used in these experiments was a singlestranded oligonucleotide complementary to the OLA probe pair (Table I, line 12 ). The OLA buffer was 20 raM Tris-Cl, pH 7.6, 100 mM KC1, 10 mM MgCl 2 , 10 mM dithiothreitol, 1 mM NAD+, 0.1 % Triton X-100 (33) . Five units of thermoresistant ligase from a Thermus species [34] (gift from Francis Barany, Cornell University Medical College) were used in each 20 til reaction.
The thermal cycle for studying ligation kinetics entailed denaturation at 94 °C for 15 s followed by probe annealingligation at 56°C for times varying from 30 s to 20 min. In the endpoint reactions, the cycle conditions were 94°C for 15 s and 56°C for 20 min. After a single thermal cycle, the enzyme was inactivated at 99°C for 10 min. The OLA was performed in the GeneAmp PCR System 9600 using MicroAmp reaction tubes with cap (Applied Biosystems Division of the Perkin Elmer Corporation, Foster City, CA).
Multiplex PCR amplification of CFTR exons PCR amplifications of genomic DNA (100-300 ng) from cultured lymphoblasts or peripheral blood were performed in a Perkin Elmer 9600 DNA thermocycler. DNA sequences spanning individual CFTR exons were amplified from PCR primers located in their respective flanking introns (35) . Sequences of the PCR primers used to amplify regions of the CFTR gene are given in Table II . Amplification reactions were carried in a 50 /il reaction volume containing the following components: 10 mM Tris-HCl pH 8.3, 50 mM KC1, 3.0 mM MgCl 2 , 0.01% gelatin, 400 /tM in each dNTP, 20-40 pmol of each primer, 100-300 ng of human genomic DNA and 2.5-5.0 U of Amplitaq DNA polymerase. Amplification conditions consisted of an initial denaturation for 5 min at 95°C, followed by 30 cycles of 94°C for 30 sec, 72°C for 90 sec and a final extension of 10 min at 72 °C. A 10 ii\ aliquot of the PCR reaction mixture was analyzed by electrophoresis in a 2% MetaPhor agarose gel (FMC BioProducts) at 100 V for 5 to 10 h in 1XTBE buffer. HaeUI digested pBR322 DNA was used as a size standard for electrophoresis. Aliquots (1.0 pi) of the amplified DNA products were used for multiplex oligonucleotide ligation assay analysis.
Multiplex oligonucleotide ligation assay of CFTR mutations
OLA reactions for 9 CFTR mutations, 7 located in exon 11 and 2 located in exon 20, were multiplexed together. Three synthetic oligonucleotide probes were used for the analysis of each mutation, two upstream (allelic) probes with 5' HEO tails of varying length, and one common, downstream, 5'-phosphorylated and 3'-FAM labeled reporter probe. The sequences of these probes are given in Table HI. All multiplex OLA reactions were carried out in 20 pi reaction volumes containing 100 mM KC1, 20 mM Tris-HCl pH 7.6, 10 mM MgCl 2 , 1 mM NAD+, 10 mM of each oligonucleotide probe, 1.0 pi of PCR amplified DNA samples, and 20 U of thermostable Thermus aquaticus DNA ligase (33, 34) . Linear amplification of product was achieved by 5 cycles of 94°C for 2 min, 54°C for 3 min in a Perkin Elmer 9600 DNA thermocycler.
Slab gel apparatus and method
For analysis of OLA kinetics, 2 pi of a mixture of OLA products were mixed with 4 pi of a 5:1 mixture of deionized formamide and 50 mM EDTA containing 5 fmoles of a FAM-tagged 35 nt oligonucleotide as a quantitative reference. For the multiplex OLA of CFTR mutations, aliquots of the multiplex OLA products (2 n\) mixed with to 2.5 /il of deionized formamide and 0.5 /tl of GENESCAN-2500 ROX size marker. The DNA was denatured at 94 °C for 2 min then cooled on ice prior to loading the entire mixture onto the gel. The products from the OLA reactions were electrophoresed on an automated Model 373A fluorescence-scanning DNA sequencer (Applied Biosystems Division of the Perkin Elmer Corporation, Foster City, CA) using an 8% acrylamide, 19:1 acrylamide:bis-acrylamide, denaturing gel containing 8 M urea, 89 mM Tris, 89 mM boric acid, and 2 mM EDTA, at pH 8.3. Gels for studies of OLA kinetics were electrophoresed for 6 h at 1200 V. CFTR multiplex OLA gels were electrophoresed 5 h at 1500 V. The migration distance to the detector was 24.5 cm; the overall gel length was 40.5 cm; and the gel thickness was 0.4 mm. The resulting gel data were analyzed for peak color, migration time, fragment size and peak area using the GENESCAN™ 672 Fragment Analysis software (Applied Biosystems Division of the Perkin Elmer Corporation, Foster City, CA).
For the kinetic studies, peak area was corrected for migration velocity and sample loading error by dividing each area value by the peak migration time and dividing the velocity-corrected area by the velocity-corrected area of the FAM-tagged 35-nt internal standard peak.
Capillary electrophoresis apparatus and method
The configuration of the capillary electrophoresis apparatus, the operating conditions, the modification of the inside wall of the capillary, the preparation of the linear poly acrylamide used as a sieving network, and the preparation of the sieving buffer solution was as described elsewhere (36) .
Sample preparation for the CE analysis was as described above for the slab system. Samples were introduced into the capillary using electrokinetic injection by applying a voltage of 6 kV for 5 s while the cathodic end of the capillary and the cathode were immersed in the sample.
RESULTS
Effect of HEO tails on melting temperature
When melting curves were measured for 12 to 14 nt oligonucleotides annealed to 42 to 45 nt oligonucleotide targets with 6 to 25 nt overhangs at both ends, addition of an HEO mobility modifier to one end of the shorter oligonucleotide reduced T m by 0.5 to 1.9°C (See Table IV ). This effect was Table I ) having HEO tail lengths of 0, 1, 3, 9, 10, 11, 23, 24 units. The numbers above each peak indicate the number of attached HEO units. Data are from an 8% crosslinked polyacrylamide slab gel in 8 M urea, (b) Electrophoretogram of same set of modified ligation products as in Figure 6 , analyzed by capillary electrophoresis in an entangled polymer network in 8 M urea.
seen for mobility modifiers ranging in length from 5 to 17 HEO units, whether attachment occurred at the 5' end or the 3' end of the oligonucleotide. The magnitude of the duplex destabilization showed no systematic dependence on mobility modifier length or duplex concentration. Similar but slightly greater destabilization (maximum value 2.8°C) occurred in the absence of MgCl 2 (data not shown), implying that the differential Mg 2+ binding affinity or stoichiometry between duplex and single stranded DNA is somewhat greater in the presence than in the absence of a mobility modifier.
Effect of HEO tails on ligation efficiency
In the OLA, two DNA probes are annealed to their complementary target DNA and joined by DNA ligase. The upstream probes of the present OLA design were 5' end-labeled with (HEO) n -units, and the downstream probes were 3' endlabeled with 5-carboxy fluorescein (FAM). The (HEO) n -units imparted a different mobility to each of the ligation products, allowing separation by denaturing polyacrylamide gel electrophoresis. Labeling the downstream probe with the FAM dye permitted visualization of the ligated products in the gel separation system. A kinetic OLA experiment measured the ligation time course for probes with a limited set of mobility modifiers, and an endpoint experiment compared the ultimate amount of product generated after 20 min with a larger range of mobility-modifier lengths.
When product appearance was tracked over reaction times ranging from 30 s to 20 min (Figure 1 ), HEO 9 and HEO 24 reduced the ligation rate by about 30% in comparison to probe lacking a mobility modifier, without affecting final product yield. The observed endpoint and the theoretical endpoint predicted from the amount of target added differed by a factor of two. Given the inherent experimental uncertainties of the relevant parameters, including the extinction coefficient used to calculate the target concentration (± 20%), the quantum yield of the fluorescent tag (±30%), and the reagent dilution factors (± 1 % per transfer), this difference is not considered significant. The endpoint experiment (Figure 4 ) measured the effect of HEO tail on the ultimate amount of OLA product produced. Mean OLA yields for duplicate reactions with different HEO tails ranged from -18% to +14% of the mean yield over all reactions and showed no significant dependence on mobility-modifier length. Figure 3a shows an electropheretogram of 8 mixed 47 nt OLA ligation products, each product having a 0-, 1-, 3-, 9-, 10-, 11-, 23-or 24-unit HEO tail, run in an 8% crosslinked polyacrylamide slab gel under denaturing conditions. Each of the ligation products was generated after annealing of oligonucleotide 10 ( Table I) and one of the oligonucleotide 11 species (Table I) to the oligonucleotide 12 target sequence (Table I) . Resolution of fragments having HEO tails differing in size by one HEO unit is achieved to at least 24 units (data shown for HEOo-HEOi, HEO9-HEO 10 -HEO n , HEO23-HEO24), providing at least 25 independent mobility addresses. Figure 3b shows a capillary separation of the same ligation products displayed in Figure 3a using a low-viscosity linear polyacrylamide solution. As before, fragments differing by a single HEO unit are clearly resolvable out to at least 24 HEO units.
Electrophoretic analysis of modified OLA ligation products
Multiplex PCR/OLA assay of CFTR mutations
Results of multiplex analysis of 9 loci in the CFTR gene are shown in Figure 4 . Sequences at all 9 loci were detected simultaneously by mutiplex OLA reactions. Coding of the OLA products with HEO mobility modifiers resulted in electrophoretic resolution OLA products. Size calculation using an in-lane molecular size standard showed that each HEO unit imparts a mobility shift equivalent to about 2.5 nucleotide units (Table V) . The nucleotide equivalent sizes of each OLA product given in this table allows easy interpretation of OLA product bands.
DISCUSSION
Effect of HEO tails on melting temperature
The effect on oligonucleotide T m of mobility modifiers ranging in size from 5 to 17 HEO units was too small to affect the practical utility of modified oligonucleotides as primers or probes, but was significant and systematic enough to indicate general duplex destabilization by the mobility modifier. The simplest explanation for diis phenomenon is that the mobility modifier random coil significantly masks the single-stranded oligonucleotide random coil to decelerate the annealing reaction without affecting the denaturation rate. As the melting equilibrium constant is the ratio of the denaturation rate constant to the annealing rate constant, selective reduction of the latter would increase the melting equilibrium constant, thereby reducing T m . This hypothesis implies a purely entropic destabilization mechanism and therefore the independence of this effect from oligonucleotide concentration (37) . Although data collected over a 25-fold DNA concentration range, with and without 10 mM MgCl 2 , showed some variation in the destabilizing effect of mobility modifiers, there was no systematic effect of DNA concentration (not all data shown in Table IV ). Figure 1 shows clearly that HEO mobility modifiers decelerate ligation by about 30%, under conditions where probe-target anealing is rate controlling. This kinetic effect is consistent with the rate reduction predicted from the melting experiments, assuming that probe annealing is rate controlling for probe ligation; a reasonable assumption given the 5 nM probe concentration. However, at the probe concentrations normally used for OLA, i.e. 10 nM, this effect is negligible. Figures 1 and 2 both indicate no systematic effect of mobility modifiers on ligation yield, but the experimental design practically assured this result. When the target is single-stranded, product yield should equal the target input. Practical OLA with denatured duplex DNA target, most commonly generated in a prior PCR, is potentially inhibited by the reannealing of the duplex target, a process controlled kinetically by the target concentration and length (38) . Slower ligation reactions (e.g., involving longer mobility modifiers) are more likely to be yield-limited by target reannealing than are faster ligation reactions, because they are less likely to have run to completion when target reannealing becomes significant. Increasing the probe concentration is the simplest way to minimize this effect, as the ligation rate is proportional to probe concentration.
Effect of HEO tails on ligation efficiency
Multiplex analysis of CFTR ligation products
For the CFTR multiplex OLA assay, probes were designed to melt within a narrow temperature range in order to give uniform annealing thermodynamics and kinetics for different alleles and loci. Consequently, the products of this multiplex OLA lie in too narrow a size range to allow practical electrophoretic resolution without the aid of some sort of mobility modifier (Table  V) . The ideal oligomeric mobility modifier should not affect annealing specificity and should perturb mobility more efficiently than an oligonucleotide containing the same number of monomeric units. Without the latter condition, mobility modifier addition during automated oligonucleotide synthesis might exact an unacceptable toll on probe synthesis and purification economics. The shift in mobility between ligation products differing in structure by a single HEO unit is 2-3 times that expected from the addition of a single nucleotide in the respective separation systems (Table V) . Somewhat closer spacing would still be analytically acceptable. This can be readily obtained by shortening the migration distance used in the electrophoretic separation. HEO n mobility modifiers also have a negligible affect with respect to OLA ligation efficiency with PCR product targets (Figure 4) . Variations in OLA product yield seen in Figure  4 can more likely be attributed to the high degree of overlap of the probes used in the exon 11 mutational hotspot (G542X, S549N, S549R2, G551D, R553X, R560T).
The four-color automated DNA sequencer used to collect the data in Figures 1 through 4 has two features which increase the practical power of multiplex OLA followed by Sequence-Coded Separation. In the multiplex OLA data shown in Figure 4 , singlecolor monitoring provides 18 multiplex addresses created by HEO-induced mobility differences and four-color capability could increase this multiplex capacity three-fold, enough for simultaneous genetic analysis of 30 biallelic loci per gel lane. Standard gels can hold up to 36 adjacent lanes, allowing potential for simultaneous analysis of 30 loci on 36 samples.
An alternative to traditional slab-gel electrophoresis which provides increased performance and degree of automation is capillary electrophoresis in entangled polymer solutions (35, 39) , where the traditional slab format is replaced by a narrow-bore capillary and the rigid gel typically used as a sieving network is replaced by a flowable polymer solution. This system eliminates the need for gel preparation and manual sample loading and allows the use of much higher electrical field strengths, thereby improving separation speed, throughput and resolution. The speed improvement, which is a direct result of the higher electrical fields used in CE separations as compared to traditional slab gels, is clearly evident from the eight-fold difference in the timescales of Figure 3a and b. In fact, the CE analysis could be made even faster. In Figure 3b , the resolution between neighboring peaks is greater than that required for unambiguous identification. Allowing more space between the peaks than is needed wastes analysis time. A shorter capillary would accelerate the separation and could be length-adjusted to attain the minimal acceptable resolution. Furthermore, in analogy to multi-well slab gel electrophoresis, sample throughput of the capillary system could be increased by running multiple capillaries in parallel (40) .
A CE system can eliminate the imprecision, delay, occupational hazard and labor requirements of gel pouring. A flowable, noncrosslinked, polymeric sieving matrix can be manufactured reproducibly as an analytical reagent which can be replaced automatically in a matter of minutes after each separation. The CE format also makes possible automatic sample loading. Here too the level of automation and reproducibility would be increased.
Significance and applications
The oligo ethylene oxide mobility modifiers in this report have several advantages over missense oligonucleotide tails. First, because the mobility increment per monomer is several times that of a nucleotide, synthesis of probes with practical electrophoretic resolution requires many fewer cycles on the automated synthesizer, resulting in higher probe purity and yield. Furthermore, the cost of HEO phosphoramidites is similar to that of nucleotide phosphoramidites, as are coupling yields and cost per cycle. While the HEO phosphoramidite is available commercially from Clontech (Palo Alto, CA), we have chosen to synthesize our own as described in the Methods section. Oligonucietides containing as many as 24 HEO units have been purified and used successfully, as shown in Figures 1-4 .
Second, the potential for oligo ethylene oxide mobility-modifier interference with probe-target annealing and ligation is less than that of a missense oligonucleotide tail.
Third, and most importantly, extending the practical mobility range proportionately increases the scale of the multiplex which can be resolved with a given separation technology.
The combination of PCR, OLA and Sequence-Coded Separation fits naturally with the functional needs of genetic disease and individual identity testing, including the study of oncogenes, tumor suppressor genes and transplantation antigen matching. These target systems involve single-nucleotide allelic differences at many, sometimes closely spaced, loci, and require confident discrimination of heterozygotes from homozygotes in a diploid setting. The ability to analyze simultaneously for all alleles at tens of loci in a single thermally cycled amplification/ligation tube and a single electrophoresis lane or capillary run would open the door to economical, large-scale, genetic screening or DNA profiling. The same multiplexing power could also broaden infectious disease testing by enabling the design of economical, symptom-specific panels which discriminate among many pathogens simultaneously and scan for drug resistance, or permit the simultaneous mapping of multiple loci across a genome. The present improvement in probing shifts the performance limitation of multiplex genetic analysis to the prior amplification step.
